Amneal Pharmaceuticals, Inc. (AMRX)
11.81
-0.11
(-0.92%)
USD |
NASDAQ |
May 19, 16:00
11.80
-0.01
(-0.08%)
After-Hours: 20:00
Amneal Pharmaceuticals Cash from Investing (Quarterly) : -21.71M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Viatris, Inc. | 277.40M |
| Pfizer Inc. | 785.00M |
| Crinetics Pharmaceuticals, Inc. | -252.36M |
| Prestige Consumer Healthcare, Inc. | -3.414M |
| Amphastar Pharmaceuticals, Inc. | -16.73M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -28.72M |
| Cash from Financing (Quarterly) | -57.07M |
| Free Cash Flow | 186.11M |
| Free Cash Flow Per Share (Quarterly) | -0.1533 |
| Free Cash Flow to Equity (Quarterly) | -57.88M |
| Free Cash Flow to Firm (Quarterly) | 1.478M |
| Free Cash Flow Yield | 4.83% |